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Abstract 
 
Surgery for spinal metastases remains the mainstay treatment for pain, instability and 
neurological deterioration due to tumor infiltration of the spine. However, several new 
therapies are emerging which may improve outcomes further, and in some cases even replace 
the need for surgery. We now have a better understanding of which factors influence survival 
and quality of life after surgery, and this underpins the development and application of new 
treatments, and assessment of outcome.  
Depending on genetic subtyping of tumors, novel immunotherapies and chemotherapies may 
be very effective in prolonging quality of life. New surgical techniques allow smaller, quicker 
and safer operations with less blood loss, pain, and quicker recovery after surgery. Radiation 
treatments have also leapt forwards with more accurate beams and higher doses possible from 
intensity modulated photon radiation, stereotactic body radiation treatment, proton beam 
therapy, or carbon ion treatment. Combined with more advanced materials for vertebral body 
stabilization, computer navigation systems and robotics, more can be done at earlier or later 
stages of the spinal disease than previously possible, resulting in more options and improved 
outcomes for patients.   
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Introduction 
 
Surgery for symptomatic spinal metastases can improve pain, neurological function, and 
quality of life.1-3 In recent years there have been several advances which contribute to better 
outcomes for this common disease. Understanding the factors which influence duration of 
survival and quality of life can help doctors and patients to make appropriate treatment 
decisions2,4-6 and genetic subtyping, novel immunotherapies, and advances in radiation 
techniques have allowed personalized treatment for patient benefit.  Advances in surgical 
techniques permit minimally invasive augmentation of vertebral body integrity without 
resorting to larger open surgeries, and thereby decrease pain and allow rapid recovery from 
surgery. Percutaneous cement augmentation, vertebral body stenting or support, and 
percutaneous instrumentation have increased the accessibility of surgical treatments to 
patients with poorer prognosis. New materials and devices for spine reconstruction can make 
surgery easier, and radiolucent materials permit more effective radiation treatments and 
radiological surveillance after surgery.  Three-dimensional printing allows bespoke 
manufacture of components to reconstruct the spine, or produce patient-specific models of 
the spine to allow the surgeon to plan tumor resection and reconstruction more effectively. 
The availability of computer navigation systems and robotic guidance allows accurate 
placement of pedicle screws, and better appreciation of abnormal anatomy.  
 
Personalized treatment 
 
Genetic subtype analysis  
Genetic analysis of tumors has revolutionized medical management of metastatic tumours, 
particularly breast carcinoma, melanoma, and certain lung carcinomas.7,8 
For Non-small cell lung cancer, if genetic analysis is positive for EGFR mutation then 
patients may respond well to immunotherapy (Erlotinib9) and chemotherapy (Pemetrexed-
Cisplatin10) with a favourable median survival of greater than 2 years. If genetic analysis is 
positive for ALK-EML fusion then immunotherapy with Crizotinib may be used.11  
Renal cell carcinoma can be resistant to radiotherapy and traditional chemotherapy, but may 
respond well to new immunotherapies (Sunitinib and Pazopanib) with more than 50% disease 
control rate.12 
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Melanoma with positive BRAF mutation may also respond well to immunotherapies with 
improved survival even in advanced metastatic disease.13  
 
Prognostication and risk assessment 
Prognostic scores allow an estimation of survival and quality of life which may guide 
treatment decisions. It is important to tailor the most appropriate operation for an individual 
patient; too much surgery, or performing surgery too late, may not benefit a patient, and 
conversely, too conservative an approach may deny a patient the chance to walk. Prognostic 
scoring systems allow a better understanding of the risk of the spine tumor to the patient, 
estimating survival and quality of life. In general, larger operations may potentially improve 
long-term outcomes, but are perhaps more likely to be associated with surgical complications 
that could negate the benefits of surgery. To select appropriate operations, it is useful 
(although not always easy) to estimate whether a patient may not live long enough to 
appreciate the effects of surgery.  
The most cited scoring systems for metastatic spine tumors are the Tomita score4 and the 
Tokuhashi score5 which comprise the primary tumor type, presence of visceral metastases, 
number of spinal metastases, and in addition the Tokuhashi score incorporates the 
neurological function and Karnofsky functional status into the score. These systems have 
been validated2,14,15 and although there are limitations to their application they remain useful 
tools to aid surgical decision making. Other prognostic scoring systems follow similar 
methodologies, but place emphasis and weighting on different variables.16  
However in this present decade, genetic subtype analysis has allowed the prognosis of certain 
tumor types to be estimated more specifically for an individual. Prognosis of some tumors are 
defined more by their genetic subtype analysis rather than other factors at presentation. 
Although generalized prognostic scoring systems still have their uses, wider acceptance and 
adoption into clinical practice has been limited and some surgeons have questioned their 
validity,17 particularly since prognosis is perhaps more influenced now by genetic subtyping. 
For example, if a melanoma metastasis has a BRAF mutation in the genetic phenotype of the 
primary tumor, then survival is influenced by the response to immunotherapy rather than by 
the number of spinal and visceral metastases at presentation. The same can be said for EGFR 
receptor status in non-small cell lung carcinoma, and Estrogen, Progesterone or HER2 
receptor status in breast carcinoma. Therefore, rather than rely on prognostic scoring systems, 
the more “modern” approach would be to create a risk stratification model including the 
genetic subtype of the metastasis, as well as the Tomita or Tokuhashi elements, to determine 
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a median survival for an individual patient at the time that they present to the surgeon. It is 
important for the modern spine surgeon to understand primary tumor biology and how this 
impacts on prognosis and consequently the choice of surgery.  
 
Advances in radiation and heavy particle therapies 
 
Traditionally, surgical management would precede adjunctive radiation treatments. However 
with the advent of modern radiotherapy, including Intensity Modulated Radiotherapy 
(IMRT), Stereotactic Radiosurgery and Radiotherapy (SRS, SBRT), and heavy particle 
therapies, the landscape has shifted. If there is no imminent instability or symptomatic spinal 
cord compression, these techniques may be used before or instead of surgery. Surgery, rather 
than aiming to completely excise a tumor, may now be performed with the objective of 
“separation surgery” to create sufficient space around crucial structures such as the spinal 
cord to allow dose escalation of radiotherapy techniques whilst limiting collateral damage to 
the spinal cord.  
Radiation treatments have seen a revolution in the past decade, with the introduction of 
stereotactic radiotherapy, SBRT18,19 and heavy particle therapy such as Proton beam or 
Carbon Ion treatments. Whereas there is little published evidence for the efficacy of heavy 
particle treatment for spinal metastases, the principal benefits would be similar to SBRT, with 
higher delivered dosage and less collateral damage. SBRT has been used for primary 
treatment, post-operative treatment, and for salvage re-irradiation. A treatment dose of 
stereotactic radiotherapy can be given to early metastases to minimize progression to spinal 
cord compression or mechanical instability, particularly for radioresistant tumors such as 
renal cell carcinoma, sarcoma, melanomas. If there is significant instability or spinal cord 
compression, primary surgical management is preferable to SBRT, although SBRT may be 
used as a post-operative adjunct after minimal access surgery.18 In addition to local disease 
control, SBRT may also have a significant role in palliative treatment of patients with end-
stage disease, resulting in pain control in 80-85% of patients.20 However, one must bear in 
mind that focused high dose radiation therapies such as SBRT can be associated with delayed 
vertebral fracture in 11-39% of patients and therefore strategies to anticipate and mitigate this 
risk, including prophylactic vertebroplasty, should be considered.21 
 
Advances in surgical technique 
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Several new techniques have been developed over the past decade to make surgery for spinal 
metastases safer and more acceptable to patients by decreasing post-operative pain and length 
of hospital stay. Minimal access techniques are a useful addition to the range of techniques 
that a spine tumor surgeon should be familiar with. However “one size does not fit all” and 
the choice of technique will depend on surgeon-related factors such as technical ability and 
familiarity with newer techniques, and patient-related factors including the reason for surgery 
(pain control, stability, decompression, or separation surgery) and the patient’s prognosis. 
Pre-operative MRI and CT imaging of the spine are essential to appreciate the anatomical 
goals of surgery and the potential limitations of certain approaches. Minimal access 
techniques in general are associated with a learning curve and require additional training, due 
to the relatively narrow working channels or approaches, longer working distances and 
challenges posed by excessive bleeding or CSF leakage.  
 
Percutaneous vertebral body augmentation 
Less invasive techniques potentially allow quicker recovery, lower complication rates, and 
increased versatility for treating palliative patients who have a poorer prognosis. The 
introduction of percutaneous cement techniques for osteoporotic vertebral body compression 
fractures has been successfully applied to pathological fractures due to spinal metastases. 
Vertebroplasty involves the injection of viscous Polymethylmethacrylate (PMMA) bone 
cement in situ to provide structural integrity within the weakened vertebral body.22,23 Xie et al 
reported decreased pain visual analogue score from around 8,4 to 3.4 after vertebroplasty in 
47 patients with spinal metastases.22 Kyphoplasty, by temporarily inflating a balloon within 
the affected vertebral body, creates a cavity which can be filled with bone cement at lower 
injection pressure than vertebroplasty, and may also permit reduction of a wedge fracture.24 
Alternative techniques to improve pathological wedging include mechanical elevation of the 
end plate using an expandable jack25 or using a titanium mesh vertebral body stent that 
expands over an inflatable balloon.26  
 
Percutaneous radiofrequency ablation 
With the development of percutaneous access to the vertebral body for cement augmentation, 
other techniques have been developed to ablate tumor in an attempt to improve spinal pain 
and possibly decrease the risk of cord compression. Radiofrequency ablation can be 
performed at the same time as percutaneous cement augmentation, or as an independent 
procedure to destroy tumor tissue within the vertebral body.27,28 Long term outcomes are 
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unclear, but this technology may be a useful addition to the minimally invasive methods 
available for palliative treatment.   
 
Minimal access retractor systems  
Anterior approaches to the vertebral body in the thoracolumbar spine is facilitated by 
minimal access retractor systems which allow smaller skin incisions and direct approaches to 
the surgical target. Corpectomy and stabilization with an expandable vertebral body 
replacement prosthesis is now possible with minimal tissue damage, allowing rapid patient 
mobilization and discharge from hospital, without the morbidity of major thoracotomy or 
anterolateral abdominal approaches. Transferring open surgical skills to using minimally 
access retractors is relatively straightforward and intuitive, unlike the steeper learning curve 
of endoscopic surgical techniques.29 Uribe et al reported a mean operating time of 117 
minutes, 291mls of blood loss, and hospital stay of 2.9 days for minimal access thoracic spine 
surgery. Although there is limited evidence of efficacy, and most published series are 
uncontrolled and report small numbers of patients, the general consensus is that these 
approaches decrease bleeding and pain compared to traditional open approaches, as discussed 
in two thorough reviews.30,31 
Posterior minimal access approaches are perhaps easier to adopt due to familiarity of 
anatomy with traditional open approaches. Several minimal access retractor systems have 
been engineered to allow insertion of pedicle screws and vertebral body replacement cages 
with minimal disruption of normal anatomy by posterior transpedicular approaches.32,33  
 
Thoracoscopic procedures 
Endoscopic procedures for minimal access to thoracic spine metastases allows surgery to be 
performed without the major morbidity of an open thoracotomy, and a lower risk of 
intercostal neuralgia, pleural effusions and hematoma.34,35 However the learning curve for 
these techniques is steeper than mini-open approaches, and may involve more blood loss and 
length of surgery than conventional techniques.29 Thoracoscopic surgery necessitates 
additional investment in equipment, surgeon and staff training, and requires an experienced 
assistant who is familiar with the technique. A study of thoracoscopic vertebral body 
resection found a mean operating time of 4.9 hours, and patient stay of 8.2 days.36 
 
Advances in pedicle screw technology 
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Percutaneous pedicle screws  
Percutaneous pedicle screws, placed using a Jamshidi bone needle and Kirschner guide wires, 
have revolutionized the indications for posterior fixation. Previously, surgery would be 
discouraged in patients with an anticipated life expectancy of less than 3 months. However, 
clinicians often do not correctly estimate a patient’s life-expectancy,37 and patients with a 
poor life expectancy may nevertheless benefit from stabilization to help back pain. 
Percutaneous pedicle screws may be offered to patients with poor prognosis for palliative 
stabilization and pain relief, and have effectively moved the goal-posts for offering fixation 
surgery. Percutaneous screws have been used often for the treatment of lumbar degenerative 
disk disease, and small series have demonstrated lower complication rates and less atrophy of 
the Multifidus spinal muscles compared to open approaches.38,39 
 
Figure 1 
 
Carbon fiber screws  
Carbon fiber reinforced PEEK (Poly-ether-ether-ketone) pedicle screws are now available 
from several manufacturers, with a high (greater than 60%) carbon fiber proportion. Strength 
is uniquely provided by unidirectional extruded carbon fibers, and is equivalent to standard 
titanium screws. Short non-metal carbon fiber rods are also available, allowing a radiolucent 
fixation system to be employed for spinal metastases. These systems have two main 
advantages: by decreasing the artifact on MRI or CT imaging, screw placement and 
surveillance for tumor recurrence is easier to observe; and carbon fiber constructs are 
associated with less shielding and scattering of radiotherapy which is often used for patients 
with spinal metastases after surgery, allowing higher and more accurate dose delivery.  
 
Figure 2 
 
Figure 3 
 
Over the past few decades the proportion of elderly patients in society has increased. 
Combined with better medical treatment of primary tumors and improved survival, it is now 
more common for patients to present with metastatic disease and co-existent osteoporotic 
vertebrae. Pedicle screws have been developed with fenestrations that allow 
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Polymethylmethacrylate bone cement to be injected through the screw into the vertebral body 
to decrease the risk of screw pull-out and failure.40,41  
An alternative strategy to minimize screw failure is to use expandable screws. After insertion 
of the pedicle screw, an internal mechanism shortens the screw and allows the slotted tip to 
expand, thereby increasing the purchase of the screw within osteoporotic bone.42 
 
Interdisciplinary team-working 
 
The majority of patients with metastatic spine disease should be discussed in a 
multidisciplinary forum, including spine surgeons, oncologists, radiotherapists, radiologists, 
pathologists, nurse practitioners, and ultimately with the patient, to determine the best 
treatment modality. Often surgery may not be the preferred treatment option, and in 
particular, elderly patients or patients with a poor prognosis require considerable thought 
prior to surgical management.43 A major advance in the treatment of spinal metastases has 
been the widespread realization that collective decision-making is essential to determine the 
best management for this complex patient group, and the development of weekly spine tumor 
meetings to discuss patient options is now common.   In addition, multidisciplinary 
discussion and consultation can be facilitated using a “virtual consult” system using 
electronic communications techniques.44  
 
Advances in materials 
 
PEEK, and Carbon fiber re-inforced PEEK are now widely available materials used for 
vertebral body replacement cages, and pedicle screw-rod systems. They have excellent 
resilience and similar strength to titanium constructs, but with the advantage of radiolucency 
for subsequent imaging, and improved radiation treatment delivery.45 Modern engineering of 
expandable cages allows easier insertion of a smaller cage which is then expanded in situ, and 
can be filled with bone graft or artificial bone substitutes. Titanium products continue to be 
used widely, with excellent handling characteristics, and visibility on x-ray which allows easy 
insertion and surveillance.  
In many units, the use of PMMA bone cement is re-emerging, allowing custom shaping of 
supports and constructs at the time of surgery, secured in situ by press-fit or the use of 
Kirschner wires to stabilize the cement block, or containing the cement within mesh or block 
cage.46  
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Three-dimensional printing of plastic polymer or titanium constructs is a new development 
which allows custom shapes and supports to be created for individual patients, after CT-scan 
planning. This technique is of particular value for regions with complex anatomy including 
the upper cervical spine and craniovertebral junction.47 Polymer or titanium powder is built 
up in successive two-dimensional layers to create a computer generated three-dimensional 
structure which can be used as a custom implant. 
 
Advances in spine navigation and robotic guidance 
 
Traditionally, pedicle screws can be inserted using two-dimensional x-ray screening for 
accurate placement. In cases of small pedicles, obese patients, and surgery at the 
cervicothoracic junction, it can be difficult to accurately visualize the relevant anatomy with 
an intra-operative image intensifier x-rays, and in these circumstances, a navigation system 
may have advantages. 
Frameless spine navigation and robot-assisted guidance rely on an intra-operative CT scan or 
image intensifier image which can be cross-referenced to the patient by optical or infrared 
camera registration. The trajectory of screws can then be calculated using the computer 
system, with potentially better accuracy and less radiation exposure than conventional pedicle 
screw techniques.48,49  
 
Conclusion 
 
Surgery plays a pivotal role in the management of patients with symptomatic spinal 
metastases. Good technical surgery performed in appropriate situations can dramatically 
improve quality of life and survival. However, occasionally, complications of surgery can 
have a negative impact on the patient, particularly in those patients with a poor prognosis and 
limited life expectancy. Although improvements in the medical management of cancer 
potentially may decrease the need for surgery in the future, it may also have the opposite 
effect: to increase the number of patients presenting to surgeons in advanced age and with 
more extensive spinal metastases. Navigated minimal access surgery, with fewer 
complications and less post-operative pain, is likely to have an important role in the future, 
hand-in-hand with advances in immunotherapy and radiation techniques. The multimodality 
treatment of spinal metastases requires close communication across several medical and 
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surgical specialties, and open discussion with the patient to decide the most appropriate 
treatment plan in each case. 
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FIGURE LEGENDS 
 
Figure 1 
Percutaneous pedicle screw stabilization.  
A. MRI of T11 melanoma metastasis, in a patient with multiple skin lesions, liver, lung 
and brain metastases, presenting with back pain. 
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B. Lateral X-ray showing percutaneous pedicle screws as palliative treatment for pain  
 
C. Antero-posterior X-rays  
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Figure 2 
Carbon-fiber reinforced PEEK pedicle screws. 
A. Carbon fiber screws with titanium polyaxial head, and carbon fiber reinforced rods. 
 
B. Axial CT scan of a patient with left sided titanium pedicle screw (right side of picture) 
compared to less artifact of a right sided carbon fiber screw. 
 
 
Figure 3 
Radiological evaluation of carbon fiber components after C3 and C4 corpectomy, anterior 
cage and plate, and posterior C2 and C5 pedicle screws. Radiolucency allows more accurate 
dose planning for subsequent radiotherapy. 
A. Sagittal CT scan showing anterior carbon fiber plate and locking screws, cage and 
bone graft 
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B. Lateral cervical X-ray demonstrating radiolucency of components. The titanium 
polyaxial heads of the C2 screws, and the standard titanium C5 screws are visible. All 
carbon fiber components are represented by small radio-opaque markers at the corners 
of the vertebral body replacement cage, tips of screws, and marking the ends of the 
anterior plate and posterior rods. 
 
C. Anteroposterior X-ray  
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